Literature DB >> 7806211

Molecular cloning of the cDNA for human TrkC (NTRK3), chromosomal assignment, and evidence for a splice variant.

L M McGregor1, S B Baylin, C A Griffin, A L Hawkins, B D Nelkin.   

Abstract

TrkC is a receptor tyrosine kinase that is activated by neurotrophin-3, a factor important in the development of certain areas of the central nervous system. We have cloned and sequenced the human trkC cDNA and found that the predicted amino acid sequence is 97 to 98% homologous to the rat and porcine trkC sequences, respectively. The rat trkC has several isoforms due to alternative splicing in the tyrosine kinase domain. We cloned one human splice variant that has a nucleic acid sequence identical to the rat isoform with an insert of 14 amino acids. The human trkC cDNA also has a (CGG)n repeat in the 5'-untranslated region. This sequence was not highly polymorphic in that 79 of 80 chromosomes examined had eight repeats, while 1 chromosome had four repeats. By PCR analysis of a somatic cell hybrid panel and fluorescence in situ hybridization with the cDNA clone, human trkC was mapped to chromosome 15q24-q25.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806211     DOI: 10.1006/geno.1994.1383

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  10 in total

1.  Lampetra fluviatilis neurotrophin homolog, descendant of a neurotrophin ancestor, discloses the early molecular evolution of neurotrophins in the vertebrate subphylum.

Authors:  F Hallböök; L G Lundin; K Kullander
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

2.  Molecular analysis of trkC in the cat visual cortex.

Authors:  F Forooghian; L Kojic; Q Gu; C A Wong; S S Prasad
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

3.  Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression.

Authors:  L M McGregor; B K McCune; J R Graff; P R McDowell; K E Romans; G D Yancopoulos; D W Ball; S B Baylin; B D Nelkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

4.  Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues.

Authors:  M Yamamoto; G Sobue; K Yamamoto; S Terao; T Mitsuma
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

Review 5.  TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.

Authors:  Shivaani Kummar; Ulrik N Lassen
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

6.  Transcriptional fingerprinting of "browning" white fat identifies NRG4 as a novel adipokine.

Authors:  Mark Christian
Journal:  Adipocyte       Date:  2014-10-30       Impact factor: 4.534

7.  Polygenic in vivo validation of cancer mutations using transposons.

Authors:  Su Kit Chew; Dong Lu; Lia S Campos; Kenneth L Scott; Abdel Saci; Juexuan Wang; Adam Collinson; Keiran Raine; Jonathan Hinton; Jon W Teague; David Jones; Andrew Menzies; Adam P Butler; John Gamble; Sarah O'Meara; Stuart McLaren; Lynda Chin; Pentao Liu; P Andrew Futreal
Journal:  Genome Biol       Date:  2014-09-27       Impact factor: 13.583

8.  Expression of the neurotrophic tyrosine kinase receptors, ntrk1 and ntrk2a, precedes expression of other ntrk genes in embryonic zebrafish.

Authors:  Katie Hahn; Paul Manuel; Cortney Bouldin
Journal:  PeerJ       Date:  2020-12-22       Impact factor: 2.984

Review 9.  Endogenous Retroviral Elements in Human Development and Central Nervous System Embryonal Tumors.

Authors:  Tara T Doucet-O'Hare; Jared S Rosenblum; Ashish H Shah; Mark R Gilbert; Zhengping Zhuang
Journal:  J Pers Med       Date:  2021-12-08

Review 10.  Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia.

Authors:  Krzysztof Jędraszek; Marta Malczewska; Karolina Parysek-Wójcik; Monika Lejman
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.